Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8905 - 8912 of 12016 results
Immigration and Nationality Act 50th Anniversary Series: National Origin Quotas to Skills & Family Based Immigration
November 3, 2015| Blog| Viewpoint
CBP Announces the Expansion of Global Entry to UK Citizens
November 3, 2015| Blog| Viewpoint
EB-5 Due Diligence Matters: Industry at Point of Inflection Regarding Securities Compliance
November 3, 2015| Blog| Viewpoint
New York Wage Deduction Amendments Renewed for Another Three Years
November 2, 2015| Blog| Viewpoint
MA Health Policy Updates - Moves to Strengthen HPC and Expand Telemedicine
November 2, 2015| Blog| Viewpoint
Data Breach Planning in 10 Easy Steps: How to Think Like A Litigator
November 2, 2015| Blog| Viewpoint
Severance Payments May be Recoverable in a Company's Bankruptcy
November 2, 2015| Blog| Viewpoint
Corporate Divorce Series: An Employment Relationship Fail
October 30, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|